Clinical Trial Update: Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from AMC-UvA is investigating inhibition of the renin-angiotensin-aldosterone system in patients with Tetralogy of Fallot-related right…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Right Ventricular Dysfunction
• Tetralogy of Fallot

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Tetralogy of Fallot, Heart Defects, Congenital | Phase 2 | Status: UNKNOWN